1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
Most people may not know it, but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials – and not all of those are approved.
While investors don't need to panic, they should keep their fingers on the pulse of the economy just to be prepared. Here are four symptoms to keep an eye on.
More Investing News »